ABIONYX Pharma SA's total assets for Q2 2025 were €12.98M, a decrease of -3.51% from the previous quarter. FR:ABNX total liabilities were €7.56M for the fiscal quarter, a 25.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.